Dexametha-Zone

Q: What is the importance of Low Dose and High Dose Dexamethasone Suppression Tests?
A: Let's begin with the HPA (Hypothalamus-Pituitary-Adrenal) axis:
Cortisol suppresses the release of both CRH from the hypothalamus as well as ACTH from the pituitary.



Low Dose Dexamethasone Test:


The Overnight DST which is a type of Low Dose DST is used to rule out a hypercortisolism state or the diagnosis of Cushing’s syndrome. It is based on the principle that in a normal individual a low dose of dexamethasone is sufficient to suppress the ACTH production and hence the cortisol levels.

Procedure:

Overnight Dexamethasone test: 1 mg of Dexamethasone is given at 11pm and the cortisol level is measured at 8am. Failure to suppress the cortisol level to less than 50 nmol/L signifies Cushing's syndrome.

LDDST: 0.5mg Dexamethasone q6h for 2 days and then the plasma cortisol is measured. Plasma cortisol more than 50 nmol/L is considered abnormal.

Any abnormality on this test must be confirmed by the 24-hour urinary cortisol levels. This is the gold standard for diagnosing Cushing’s.

Limitations:
  • Certain drugs which are inducers of CYP3A4 (eg: rifampicin, anti epileptics) lead to rapid activation of DEX and hence false positives may be seen in patients taking these drugs.
  • The LDDST can also be falsely abnormal in high stress states such as starvation, alcohol withdrawal due to the elevated levels of glucocorticoids during stress.

High Dose Dexamethasone Test:


Once the diagnosis of Cushing’s syndrome is confirmed various tests are used to find out the etiology.
ACTH levels will differentiate between adrenal and extra-adrenal causes. Adrenal disease will have low ACTH levels and can then be further investigated.

Elevated ACTH levels are seen with either Cushing’s disease (Increased ACTH from a pituitary source) or ectopic production of ACTH (for ex: small cell carcinoma of lung)

The HDDST is used to differentiate the two causes of Cushing’s syndrome with increased ACTH production.
The principle is that Higher doses of Dexamethasone can successfully suppress increased ACTH production from a pituitary source but will fail to do so from an ectopic source.
This is because the tumour cells in Cushing’s disease retain some responsiveness to the level of glucocorticoids (Can be suppressed by a HDDST but lower doses fail to suppress it)  whereas ectopic tumor cells are unresponsive to the same.

Procedure: 2 mg Dexamethasone q6h for 2d is administered. Plasma cortisol is measured before and after the administration.
Cushing’s disease : Plasma cortisol suppression  to at least 50% of baseline values after DEX.
Ectopic ACTH production: failure to suppress cortisol.

However approximately 10% of patients with Cushing’s disease fail to suppress cortisol after HDDST and 10% of patients with ectopic sources suppress Cortisol

References:

1. Diagnosis and Multimodality Management of Cushing's Disease: A Practical Review -    Scientific Figure on ResearchGate. Available from: https://www.researchgate.net/A-stepwise-algorithm-for-the-diagnosis-of-Cushings-Disease-Abbreviations-ACTH_fig1_235524467 [accessed 22 Oct, 2018]

2. Nieman L.K., Beverly M.K.B., Findling J.W., Newell-Price J., Savage M.O., Stewart P.M. and Montori V.M. (2008) The Diagnosis of Cushing’s Syndrome: An endocrine society clinical practice guideline. JCEM 93:1526-1540

Written By Pranav Hinduja

Comments

Post a Comment

Popular posts from this blog

The Icebreaker: Contraction Alkalosis

Image
The Icebreaker: What is Contraction alkalosis ?? The word 'contraction' in contraction alkalosis refers to fluid contraction or in other words, fluid loss . So when the body loses fluid (typically seen with diuretics) it tries to get all that fluid back. Q: How can the body do this ?   A: By increasing the serum sodium concentration. (increased sodium concentration --> increased osmolarity of serum --> increase in intravascular volume) Q: How does the body do it ? A:1) The decreased blood volume is sensed as decreased blood pressure felt by the kidneys at the glomerulus ie. decreased renal perfusion pressure. There are modified smooth muscle cells in the afferent arteriole that detect this change called JG cells . They secrete Renin in response to the low pressures.  2) By the diagram shown below Renin activates an axis that gives rise to Angiotensin II and aldosterone.   The Renin-Angiotensin-Aldosterone axis   3) Angiotens
Read more

Are SGLT2 inhibitors renoprotective?

Image
SGLT2 Inhibitors and Renoprotection Q: “How do SGLT2 inhibitors help in chronic kidney disease?” A: The renoprotective effect of SGLT2 inhibitors is still being extensively studied, but the results have been very promising. Let’s start with discussing what SGLT2 inhibitors are. SGLT 2 inhibitors SGLT2 inhibitors (eg dapagliflozin, canagliflozin, empagliflozin etc) are a class of drugs that inhibit reabsorption of glucose in the kidney (by inhibiting the sodium-glucose transport protein 2 - ie, SGLT2) and therefore lower blood sugar. Because of their use in lowering blood glucose levels, they are regularly used in the management of type 2 diabetes mellitus (and increasingly in type 1 diabetes as well). In addition to glycemic control, they have been shown to provide significant cardiovascular benefit in patients with type 2 diabetes. Mechanism Sodium Glucose cotransporters (SGLTs) are proteins that are found in different tissues that play an important role in mai
Read more